Новые концепции и патофизиология симптомов нижних мочевых путей у мужчин

Автор: Cruz F., Desgrandchamps F.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Андрология

Статья в выпуске: 2, 2012 года.

Бесплатный доступ

Снмп, мочевой пузырь, предстательная железа, гиперактивность детрузора, иво, метаболический синдром, силадозин

Короткий адрес: https://sciup.org/142188300

IDR: 142188300

Список литературы Новые концепции и патофизиология симптомов нижних мочевых путей у мужчин

  • Neal D.E., Ramsden P.D., Sharples L. et al. Outcome of elective prostatectomy. BMJ. 1989; 299: 762-7.
  • Thomas A.W., Cannon A., Bartlett E., Ellis-Jones J., Abrams P. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of transurethral resection of prostate for bladder outlet obstruction J Urol 2005; 174: 1887-91
  • Oelke M., Baard J., Wijkstra H., de la Rosette J.J., Jonas U., Höfner K. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia Eur Urol 2008; 54: 419-26.
  • Hampel C., Dolber P.C., Smith M.P. et al Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction J Urol 2002; 167: 1513-21
  • Nomiya M., Yamaguchi O. Aquantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders J Urol 2003; 170: 649-53
  • Kawabe K., Yoshida M., Homma Y., Silodosin Clinical Study Group Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men BJU Int 2006; 98: 1019-24
  • Yokoyama O., Ito H., Aoki Y., Oyama N., Miwa Y., Akino H. Selective alpha(1A)-blocker improves bladder storage function in rats via suppression of C-fi ber afferent activity. World J Urol. In press DOI: 10.1007/s00345-009-0481-2
  • Bing W., Chang S., Hypolite J.A. et al Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase Am J Physiol Renal Physiol 2003; 285: F990-7
  • Rajasekaran M., Wilkes N., Kuntz S., E Albo M. Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats Neurourol Urodyn 2005; 24: 295-300
  • Brading A.F. A myogenic basis for the overactive bladder Urology 1997; 50(6A Suppl): 57-67
  • Levin R.M., Haugaard N., O’Connor L. et al. Obstructive response of human bladder to BPH vs rabbit bladder response to partial outlet obstruction: a direct comparison Neurourol Urodyn 2000; 19: 609-29
  • Schroder A., Chichester P., Kogan B.A. et al. Effect of chronic bladder outlet obstruction on blood fl ow of the rabbit bladder. J Urol 2001; 165: 640-6
  • Elbadawi A., Resnick N.M., Dorsam J., Yalla S.V., Haferkamp A. Structural basis of neurogenic bladder dysfunction I Methods of prospective ultrastructural study and overview of the findings J Urol 2003; 169: 540-6
  • Tse V., Wills E., Szonyi G., Khadra M.H. The application of ultrastructural studies in the diagnosis of bladder dysfunction in a clinical setting J Urol 2000; 163: 535-9
  • Drake M.J., Harvey I.J., Gillespie J.I., Van Duyl W. A. Localized contractions in the normal human bladder and in urinary urgency BJU Int 2005; 95: 1002-5
  • McCarthy C. J., Zabbarova I.V., Brumovsky P.R., Roppolo J.R., Gebhart G.F., Kanai A.J. Spontaneous contractions evoke afferent nerve firing in mouse bladders with detrusor over activity J Urol 2009; 181: 1459-66
  • Yokoyama O., Komatsu K., Kodama K., Yotsuyanagi S., Niikura S., Namiki M. Diagnostic value of intravesical lidocaine for overactive bladder J Urol 2000; 164: 340-3.
  • Dinis P., Silva J., Ribeiro M.J., Avelino A., Reis M., Cruz F. Bladder C-fi ber desensitization induces a long-lasting improvement of BPH-associated storage LUTS: a pilot study Eur Urol 2004; 46: 88-94
  • Vlaskovska M., Kasakov L., Rong W. et al P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 2001; 21: 5670-7
  • Cockayne D.A., Hamilton S.G., Zhu Q.M. et al. Urinary bladder hyporefl exia and reduced pain-related behaviour in P2X3-defi cient mice Nature 2000; 407: 1011-5
  • Steers W.D., Kolbeck S., Creedon D., Tuttle J.B. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function J Clin Invest 1991; 88: 1709-15.
  • Charrua A., Pinto R., Frias B., Cruz C.D., Cruz F. TRPV1 expression in the bladder is essential for NGF-induced detrusor overactivity Neurourol Urodynam 2009; 28: 99, abstract
  • Steers W.D. Rat: overview and innervation Neurourol Urodyn 1994; 13: 97-118.
  • Balkau B., Charles M.A. Comment on the provisional report from the WHO consultation European Group for the Study of Insulin Resistance (EGIR). Diabetes Med 1999; 16: 442-3.
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
  • Makhsida N., Shah J., Yan G., Fisch H., Shabsigh R. Hypogonadism and metabolic syndrome: implications for testosterone therapy J Urol 2005; 174: 827-34
  • Meigs J.B. Epidemiology of the metabolic syndrome Am J Manag Care 2002; 8(Suppl): S283-92
  • Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K., DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women Arch Intern Med 2004; 164: 1066-76
  • Moebus S., Hanisch J.U., Aidelsburger P., Bramlage P., Wasem J., Jockel K.H. Impact of 4 different defi nitions used for the assessment of the prevalence of the metabolic syndrome in primary healthcare: the German Metabolic and Cardiovascular Risk Project (GEMCAS) Cardiovasc Diabetol 2007; 6:
  • Maggio M., Lauretani F., Ceda G. et al. Estradiol and metabolic syndrome in older Italian men: the InCHIANTI study J Androl 2010; 31: 155-62
  • Knoblovits P., Pablo R., Costanzo P.R. et al Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting. J Androl. In press DOI: 2164/jandrol.109.007757
  • Bal K., Oder M., Sahin A.S. et al Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction Urology 2007; 69: 356-60
  • Hammarsten J., Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151-8.
  • Ozden C., Ozdal O.L., Urgancioglu G., Koyuncu H., Gokkaya S., Memis A. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia Eur Urol 2007; 51: 199-206
  • Kaplan S., Fisch H., Berriman S.J. Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms, sexual dysfunction, and components of the metabolic syndrome J Urol 2007; 177(Suppl): 497-8, Abstract 1508.
  • Kristal A.R., Arnold K.B., Schenk J.M. et al Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial J Urol 2007; 177: 1395-400
  • Desgrandchamps F., Haab F., Coloby P., Slama A., Gaudin A.F. Instant 2006: cardiometabolic markers in subjects with lower urinary tract symptoms in the French general population Eur Urol Suppl 2008; 7: 130, Abstract 237
  • Gupta A., Gupta S., Pavuk M., Roehrborn C.G. Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology 2006; 68: 1198-205.
  • Temml C., Obermayr R., Marszalek M., Rauchenwald M., Madersbacher S., Ponholzer A. Are lower urinary tract symptoms infl uenced by metabolic syndrome? Urology 2009; 73: 544-8.
  • Esposito K., Giugliano F., Di Palo C. et al Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial JAMA 2004; 291: 2978-84.
  • Platz E.A., Kawachi I., Rimm E.B. et al Physical activity and benign prostatic hyperplasia Arch Intern Med 1998; 158: 2349-56
Еще
Статья